The Wall Street Journal (WSJ) ran an interesting story recently on the type 2 diabetes medication, Avandia, and the latest study evaluating its safety.
Also known as rosiglitazone, Avandia has come under scrutiny as a result of a study published in 2007 by Dr. Steven Nissen, which found an increased the risk for heart attack in patients taking the drug. In the recent WSJ article, Nissen commented on the new RECORD trial, saying that it is “seriously flawed.”
Researchers being researchers, they will likely argue the results till the cows come home, which really isn’t very helpful if you’re taking Avandia and looking for some definitive answers.
One thing’s for certain, though, the lawyers aren’t waiting for the holy grail of scientific consensus. In fact, they’re trying to make people aware that the statute of limitations may be coming up in some states for people who are considering a lawsuit against the makers of Avandia, GlaxoSmithKline.
In a recent interview with a LAS, Jeff Lowe, with The Lowe Law Firm, said that the statute of limitations varies depending on where you live, so if you’ve suffered an adverse event while taking Avandia you’d better contact a lawyer sooner rather than later.
Just in case you’re wondering, as I was, what a statute of limitations is—a short definition is: a statute within a legal system that sets a maximum period of time in which legal proceedings based on events within that time period can be instigated. In other words, cases have expiration dates.
Better ask a lawyer…